Gabe Otte is the CEO and Co-Founder of Freenome, a liquid biopsy startup. Freenome’s goal is, in Otte’s words, to bring “accurate, accessible and non-invasive disease screenings to doctors to proactively treat cancer and other diseases at their most manageable stages.” Simply put: to detect diseases earlier and so we can treat them earlier.

Otte created and released his first public application at the age of 11. At 17, he was hired as an engineer at Apple. He previously worked as a software engineer at both Apple and the Glyde corporation. In 2014, Otte founded Acorn, a location-based messaging service. He earned an undergraduate degree in chemistry and computational biology from Cornell and did graduate work at the University of Pennsylvania. Otte also currently serves as a partner at Healthcare Co-Op in San Francisco.

Health, Healthcare, Healthcare Policy, Business of Healthcare, Innovation, Asian Heritage, Diversity, Diversity Topics Cancer, Co-founder, Start-Up Founder, CEO, Futurism, Technology, Chief Executive Officer (CEO),